Related Experiment Videos

Binding of GSK3beta to the APC-beta-catenin complex and regulation of complex assembly

B Rubinfeld1, I Albert, E Porfiri

  • 1Onyx Pharmaceuticals, Richmond, CA 94806, USA.

Science (New York, N.Y.)
|May 17, 1996
PubMed

Insights

The adenomatous polyposis coli (APC) protein interacts with beta-catenin, a key molecule in colon cancer. Phosphorylation by glycogen synthase kinase 3beta (GSK3beta) regulates this interaction, impacting cellular adhesion and signaling pathways.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cellular Signaling

Background:

  • The adenomatous polyposis coli (APC) gene is frequently mutated in colon cancers.
  • APC protein interacts with beta-catenin, a homolog of Drosophila ARMADILLO.
  • Beta-catenin is a component of the WINGLESS signaling pathway.

Purpose of the Study:

  • To investigate the interaction between APC and beta-catenin.
  • To elucidate the role of glycogen synthase kinase 3beta (GSK3beta) in regulating APC-beta-catenin binding.
  • To map the phosphorylation sites on APC.

Main Methods:

  • In vitro kinase assays to assess APC phosphorylation by GSK3beta.
  • Mapping of phosphorylation sites on the APC protein.
  • Analysis of beta-catenin binding to phosphorylated APC.

Main Results:

  • APC is a substrate for GSK3beta in vitro.
  • Phosphorylation sites were mapped to the central region of APC.
  • Beta-catenin binding to APC is dependent on GSK3beta-mediated phosphorylation.

Conclusions:

  • GSK3beta-mediated phosphorylation regulates the interaction between APC and beta-catenin.
  • This phosphorylation-dependent binding is crucial for the WINGLESS signaling pathway.
  • Findings provide insights into the molecular mechanisms underlying colon cancer development.

Related Concept Videos